Superoxide anion curbs nitric oxide modulation of afferent arteriolar ANG II responsiveness in diabetes mellitus

American Journal of Physiology - Renal Physiology

Volumn 278, Issue 2 47-2, 2000, Pages

  Schoonmaker, Gwynn C ^a   Fallet, Rachel W ^a   Carmines, Pamela K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Efferent arteriole; N( ) nitro L arginine; Rat; Streptozotocin; Superoxide dismutase

Indexed keywords

ANGIOTENSIN; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; STREPTOZOCIN; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; KIDNEY ARTERY; KIDNEY MEDULLA; MALE; NEPHRON; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 0034055323     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2000.278.2.f302     Document Type: Article

References (43)

1. Anderson, S. Physiologic actions and molecular expression of the renin-angiotensin system in the diabetic rat. Min. Electrolyte Metab. 24: 406-411, 1998.
2. Anderson, S., F. F. Jung, and J. R. Ingelfinger. Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 265: F477-F486, 1993.
3. Angulo, J., L. Rodríguez-Mañas, C. Peiró, M. Neira, J. Marín, and C. F. Sánchez-Ferrer. Impairment of nitric oxide-mediated relaxations in anaesthetized autoperfused streptozotocin-induced diabetic rats. Naunyn Schmiedebergs Arch. Pharmacol. 358: 529-537, 1998.
4. Arima, S., S. Ito, K. Omata, K. Takeuchi, and K. Abe. High glucose augments angiotensin II action by inhibiting NO synthesis in in vitro microperfused rabbit afferent arterioles. Kidney Int. 48: 683-689, 1995.
5. Bachmann, S., H. M. Bosse, and P. Mundel. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 268: F885-F898, 1995.
6. Bank, N., and H. S. Aynedjian. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int. 43: 1306-1312, 1993.
7. 1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 265: F651-F659, 1993.
8. Carmines, P. K. Segment-specific effect of chloride channel blockade on rat renal arteriolar contractile responses to angiotensin II. Am. J. Hypertens. 8: 90-94, 1995.
9. Carmines, P. K., K. Ohishi, and H. Ikenaga. Functional impairment of renal afferent arteriolar voltage-gated calcium channels in rats with diabetes mellitus. J. Clin. Invest. 98: 2564-2571, 1996.
10. Casellas, D., and P. K. Carmines. Control of the renal microvasculature: cellular and integrative perspectives. Curr. Opin. Nephrol. Hypertens. 5: 57-63, 1996.
11. Casellas, D., and L. G. Navar. In vitro perfusion of juxtamedullary nephrons in rats. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 246: F349-F358, 1984.
12. Cosentino, F., K. Hishikawa, Z. S. Katusic, and T. F. Luscher. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96: 25-28, 1997.
13. Dai, F.-X., A. Diederich, J. Skopec, and D. Diederich. Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: role of prostaglandin endoperoxides and free radicals. J. Am. Soc. Nephrol. 4: 1327-1336, 1993.
14. Diederich, D., J. Skopec, A. Diederich, and F.-X. Dai. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am. J. Physiol. Heart Circ. Physiol. 266: H1153-H1161, 1994.
15. Forti, A. C., and M. C. Fonteles. Decreased endothelium dependent relaxation (nitric oxide) in diabetic kidneys. Horm. Metab. Res. 30: 55-57, 1998.
16. Fridovich, I. Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase. J. Biol. Chem. 245: 4053-4057, 1970.
17. Goor, Y., G. Peer, A. Iaina, M. Blum, Y. Wollman, T. Chernihovsky, D. Silverberg, and S. Cabili. Nitric oxide in ischaemic acute renal failure of streptozotocin diabetic rats. Diabetologia 39: 1036-1040, 1996.
18. Ichihara, A., E. W. Inscho, J. D. Imig, and L. G. Navar. Neuronal nitric oxide synthase modulates rat renal microvascular function. Am. J. Physiol. Renal Physiol. 274: F516-F524, 1998.
19. Ikenaga, H., R. W. Fallet, and P. K. Carmines. Basal nitric oxide production curtails arteriolar vasoconstrictor responses to ANG II in rat kidney. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 271: F365-F373, 1996.
20. Kamata, K., and M. Hosokawa. Endothelial dysfunction in the perfused kidney from the streptozotocin-induced diabetic rat. Res. Comm. Mol. Pathol. Pharmacol. 96: 57-70, 1997.
21. Kennefick, T. M., T. T. Oyama, M. M. Thompson, J. P. Vora, and S. Anderson. Enhanced renal sensitivity to angiotensin actions in diabetes mellitus in the rat. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 271: F595-F602, 1996.
22. G-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus. Br. J. Pharmacol. 103: 1321-1326, 1991.
23. Komers, R., T. J. Allen, and M. E. Cooper. Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 43: 1190-1197, 1994.
24. Langenstroer, P., and G. M. Pieper. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am. J. Physiol. Heart Circ. Physiol. 263: H257-H265, 1992.
25. Lewis, E. J., L. G. Hunsicker, R. P. Bain, and R. D. Rohde. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329: 1456-1462, 1993.
26. Mathis, K. M., and R. O. Banks. Role of nitric oxide and angiotensin II in diabetes mellitus-induced glomerular hyperfiltration. J. Am. Soc. Nephrol. 7: 105-112, 1996.
27. G-nitro-L-arginine, a nitric oxide synthase inhibitor. Biol. Pharm. Bull. 18: 496-500, 1995.
28. Mattar, A. L., C. K. Fujihara, M. O. Ribeiro, G. De Nucci, and R. Zatz. Renal effects of acute and chronic nitric oxide inhibition in experimental diabetes. Nephron 74: 136-143, 1996.
29. Mayhan, W. G. Superoxide dismutase partially restores impaired dilatation of the basilar artery during diabetes mellitus. Brain Res. 760: 204-209, 1997.
30. Ohishi, K., and P. K. Carmines. Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J. Am. Soc. Nephrol. 5: 1559-1566, 1995.
31. Ohishi, K., P. K. Carmines, E. W. Inscho, and L. G. Navar. EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 263: F900-F906, 1992.
32. Ohishi, K., M. I. Okwueze, R. C. Vari, and P. K. Carmines. Juxtamedullary microvascular dysfunction during the hyperfiltration stage of diabetes mellitus. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 267: F99-F105, 1994.
33. Parekh, N., L. Dobrowolski, A. P. Zou, and M. Steinhausen. Nitric oxide modulates angiotensin II- and norepinephrine-dependent vasoconstriction in rat kidney. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 270: R630-R635, 1996.
34. Pflueger, A. C., H. Osswald, and F. G. Knox. Adenosine-induced renal vasoconstriction in diabetes mellitus rats: role of nitric oxide. Am. J. Physiol. Renal Physiol. 276: F340-F346, 1999.
35. A receptors in the hypertension produced by 4-day L-NAME and cyclosporine treatment. Eur. J. Pharmacol. 346: 43-50, 1998.
36. Reid, J. J., and M. J. Rand. Renal vasoconstriction is modulated by nitric oxide. Clin. Exp. Pharmacol. Physiol. 19: 376-379, 1992.
37. Remuzzi, A., N. Perico, C. S. Amuchastegui, B. Malanchini, M. Mazerska, C. Battaglia, T. Bertani, and G. Remuzzi. Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J. Am. Soc. Nephrol. 4: 40-49, 1993.
38. Sugimoto, H., K. Shikata, M. Matsuda, M. Kushiro, Y. Hayashi, K. Hiragushi, J. Wada, and H. Makino. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia 41: 1426-1434, 1998.
39. Tolins, J. P., P. J. Shultz, L. Raij, D. Brown, and S. M. Mauer. Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: Role of nitric oxide. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 265: F886-F895, 1993.
40. Vora, J. P., T. T. Oyama, M. M. Thompson, and S. Anderson. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes. Diabetes 46: 107-112, 1997.
41. Wang, Y. X., D. P. Brooks, and R. M. Edwards. Attenuated glomerular cGMP production and renal vasodilation in streptozotocin-induced diabetic rats. Am. J. Physiol. Regulatory Integrafive Comp. Physiol. 264: R952-R956, 1993.
42. Wilkes, B. M., P. F. Mento, and M. A. Vernace. Angiotensin responsiveness in hyperfiltering and nonhyperfiltering diabetic rats. J. Am. Soc. Nephrol. 4: 1346-1353, 1993.
43. Zatz, R., B. R. Dunn, T. W. Meyer, S. Anderson, H. G. Rennke, and B. M. Brenner. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J. Clin. Invest. 77: 1925-1930, 1986.